期刊文献+

盐替代品对心血管健康影响的研究进展

Research Progress on the Impact of Salt Substitutes on Cardiovascular Health
下载PDF
导出
摘要 心血管疾病(CVD)在21世纪初期已成为全球过早死亡和发病的主要原因,而预防和控制高血压是阻止心血管疾病发生、发展的核心措施之一。既往大量研究已表明减少食盐摄入可以降低并控制血压,食用盐替代品——即富含钾或其他类似成分(如MgCl2,MgSO4和CaCl2等)可以作为一种低成本、非药物性降压措施,但其对心血管疾病的发生、发展及与预后仍有待进一步研究。现就盐替代品对心血管健康影响的研究进行综述,以期为预防和控制心血管事件提供更具参考价值的信息。 Cardiovascular disease (CVD) has become the leading cause of premature death and morbidity in the world at the beginning of the 21st century, the prevention and control of hypertension is one of the core measures to prevent the occurrence and progression of cardiovascular disease. Previous studies have shown that reducing salt intake can lower and control blood pressure. Salt substitutes, which are rich in potassium or other similar ingredients (such as MgCl2, MgSO4, and CaCl2, etc.) can be used as a low-cost, non-pharmacological antihypertensive measure, but their impact on the occurrence, progression, and prognosis of cardiovascular disease still need further studies. This article reviews the effects of salt substitutes on cardiovascular health to provide more valuable information for the prevention and control of cardiovascular events.
作者 罗艺 佘强
出处 《临床医学进展》 2024年第4期47-52,共6页 Advances in Clinical Medicine
  • 相关文献

参考文献1

二级参考文献22

  • 1Elliot P, Stamler J. Commentary; evidence on salt and bloodpressure is consistent and persuasive[J]. Int J Epidemiol,2002,31(2):316-319.
  • 2Sacks FM, Svetkey LP, Vollmer WM, et al. For the DASH-sodiumcollaborative research group. Effects on blood pressure of reduceddietary sodium and the dietary approaches to stop hypertension(DASH) diet[J], N Engl J Med,2001,344(1) :3-10.
  • 3Cutler J,Follmann D,Allender P. Randomized trials of sodiumreduction: an overview[J]. Am J Clin Nutr, 1997, 65 (2 Suppl):S643-651.
  • 4Whelton P, He J, Cutler J, et al. Effects of oral potassium onblood pressure-meta-analysis of randomized controlled clinical tri-als[J]. JAMA, 1997,277(20) :1624-1632.
  • 5Widman L, Webster PO, Stegmayr BK* et al. The dose-depend-ent reduction in blood pressure through administration of magne-sium[J]. Am J Hypertens,1993,6(1) :41-45.
  • 6Karppanen H, Tanskanen A,Tuomilehto J, et al. Safety andeffects of potassium- and magnesium-containing low sodium saltmixtures[J], J Cardiovasc Pharmacol,1984,6 Suppl 1 : S236-243.
  • 7Geleijnse JM,Witteman JCM, Back AAA, et al. Reduction inblood pressure with a low sodium, high potassium, high magne-sium salt in older subjects with mild to moderate hypertension[J]. BMJ,1994,309(6952) :436-440.
  • 8Jeffery RW. Pirie PL, Elmer PJ,et al. Low-sodium, high-potas-sium diet; feasibility and acceptability in a normotensive popula-tion[J]. Am J Public Health,1984,74(5) :492-494.
  • 9China salt substitute study collaborative group. Salt substitution:a low-cost strategy for blood pressure control among ruralChinese. A randomized,controlled trial[J]. J Hypertens, 2007,25(10):2011-2018.
  • 10Zhou X. Liu JX, Shi R, et al. Compound ion salt, a novel low-sodium salt substitute: from animal study to community-basedpopulation trial[J]. Am J Hypertens,2009,22(9) :934-942.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部